Merkel Cell Carcinoma (MCC) is a rare but aggressive form of skin cancer that typically appears as painless, flesh-colored or bluish-red nodules on the skin. Although it accounts for less than 1% of skin cancers, its rapid growth and tendency to metastasize make it challenging to treat. Cancer research in MCC focuses on understanding its molecular pathways and developing targeted therapies. Recent advances include the identification of Merkel cell polyomavirus (MCV) as a potential causative agent, leading to the development of immunotherapies such as checkpoint inhibitors. Additionally, efforts are underway to explore combination therapies and biomarkers for early detection and personalized treatment approaches. Despite progress, further research is needed to improve outcomes for patients with this aggressive malignancy.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States